financetom
Business
financetom
/
Business
/
Inspire Medical Systems CFO Rick Buchholz to Step Down in December
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Inspire Medical Systems CFO Rick Buchholz to Step Down in December
Aug 26, 2025 2:36 PM

05:02 PM EDT, 08/26/2025 (MT Newswires) -- Inspire Medical Systems ( INSP ) said late Tuesday its Chief Financial Officer Rick Buchholz plans to step down from his position on Dec. 31 to pursue other opportunities.

Buchholz will remain with the company until the end of February 2026 in a financial advisory role for a seamless transition, Inspire Medical ( INSP ) said.

The company said it is currently looking for a new CFO.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US SEC probes MassMutual over accounting practices, WSJ reports
US SEC probes MassMutual over accounting practices, WSJ reports
Oct 8, 2025
(Reuters) -U.S. regulators are investigating Massachusetts Mutual Life Insurance over its accounting practices in investment operations, the Wall Street Journal reported on Wednesday. The Securities and Exchange Commission has issued subpoenas seeking information about MassMutual's bookkeeping around income on billions of dollars of loans it holds in its general investment account, the report said, citing people familiar with the matter....
Bicara Therapeutics Insider Sold Shares Worth $911,842, According to a Recent SEC Filing
Bicara Therapeutics Insider Sold Shares Worth $911,842, According to a Recent SEC Filing
Oct 8, 2025
05:39 PM EDT, 10/08/2025 (MT Newswires) -- Ryan Cohlhepp, Director, President and COO, on October 06, 2025, sold 50,500 shares in Bicara Therapeutics ( BCAX ) for $911,842. Following the Form 4 filing with the SEC, Cohlhepp has control over a total of 202,641 common shares of the company, with 202,641 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2023658/000203466525000004/xslF345X05/wk-form4_1759959205.xml ...
bioAffinity Technologies Launches $1.8 Million Registered Direct Offering
bioAffinity Technologies Launches $1.8 Million Registered Direct Offering
Oct 8, 2025
05:34 PM EDT, 10/08/2025 (MT Newswires) -- bioAffinity Technologies (BIAF) reported Wednesday a registered direct offering of 720,000 shares at $2.50 apiece to raise $1.8 million. The biotechnology company said it plans to use the net proceeds to support the sales of its noninvasive test for lung cancer, CyPath Lung, as well as for working capital and general corporate purposes....
Bicara Therapeutics Insider Sold Shares Worth $553,198, According to a Recent SEC Filing
Bicara Therapeutics Insider Sold Shares Worth $553,198, According to a Recent SEC Filing
Oct 8, 2025
05:38 PM EDT, 10/08/2025 (MT Newswires) -- Ivan Hyep, Chief Financial Officer, on October 06, 2025, sold 30,385 shares in Bicara Therapeutics ( BCAX ) for $553,198. Following the Form 4 filing with the SEC, Hyep has control over a total of 145,355 common shares of the company, with 145,355 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2023658/000203466825000004/xslF345X05/wk-form4_1759959228.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved